While venous thromboembolism (VTE) is rare in young women of reproductive age,
combined oral contraceptives increase the risk of VTE. In the patient in whom combined …

This review provides an update of knowledge regarding venous thromboembolism (VTE)
and combined hormonal contraceptives (CHCs) in the light of new progestins and new …

Introduction The increased risk of venous thromboembolism associated with the use of
hormonal contraception is well recognized, but evidence regarding hormonal contraception …

To date, 13 studies have provided data on the risk of venous thromboembolism associated
with combined oral contraceptives containing drospirenone or the norelgestromincontaining …

Background. New studies about the influence of hormonal contraception on the risk of
venous thromboembolism (VTE) have been published. Aim. To evaluate new …

Objective A systematic review of studies published between January 1995 and April 2010
aimed at determining the effect of combined hormonal contraceptives (CHCs), administered …

Hormonal contraception remains one of the most important contributions to women's health
in the last century. The birth control pill has dramatically changed the medical, social …

Abstract In October 1995 the Committee on Safety of Medicines advised UK doctors and
pharmacists that oral contraceptives containing desogestrel and gestodene were associated …

Combined oral contraceptives (COC) are the most popular contraceptive method in
developed countries. Since their introduction there have been numerous changes and …

Hormonal contraceptives are a popular method of contraception, but their use has been
associated with an increased risk for venous thromboembolism. In order to reduce such risk …